Vatiquinone has been shown potently suppress RSL3-induced ferroptosis in mitochondrial disease patient cell lines via inhibition of 15-lipoxygenase (15-LO)(see Discussion)(7). This evidence concerns the gene ALOX15B and inborn mitochondrial metabolism disorder.